Evidence map›Paper›PMID 12646273›Full record

ArticleArchives of biochemistry and biophysics2003

Expression and purification of recombinant tristetraprolin that can bind to tumor necrosis factor-alpha mRNA and serve as a substrate for mitogen-activated protein kinases.

Heping Cao, Frederick Dzineku, Perry J Blackshear

Open access · greenAbstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Roles of Tristetraprolin in Tumorigenesis.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The role of tristetraprolin in cancer and inflammation.Frontiers in bioscience (Landmark edition) · 2012
    Review
  20. A molecular mechanism for TNF-α-mediated downregulation of B cell responses.Journal of immunology (Baltimore, Md. : 1950) · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Heping CaoLaboratory of Signal Transduction, National Institute of Environmental Health Sciences, Mail Drop F3-04, Research Triangle Park, NC 27709, USA. cao2@niehs.nih.gov
Frederick Dzineku
Perry J Blackshear
National Institute of Environmental Health Sciences · US

Funding

TTP and related proteins in the regulation of gene expressionZIAES090080 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BLACKSHEAR, PERRY J · 2009 to 2025
$52.6M
TTP AND RELATED PROTEINS IN INFLAMMATORY DISEASESZ01ES090080 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BLACKSHEAR, PERRY J · 1998 to 2008
$5.3M
NIEHS NIH HHS Z01 ES090080-08
6 · The paper itself

Abstract

Tristetraprolin (TTP) is an mRNA-binding protein, but studies of this interaction have been difficult due to problems with the purification of recombinant TTP. In the present study, we expressed human and mouse TTP as glutathione S-transferase and maltose-binding protein (MBP) fusion proteins in Escherichia coli, and purified them by affinity resins and Mono Q chromatography. TTP cleaved from the fusion protein was identified by immunoblotting, MALDI-MS, and protein sequencing, and was further purified to homogeneity by continuous-elution SDS-gel electrophoresis. Purified recombinant TTP bound to the AU-rich element of tumor necrosis factor-alpha (TNFalpha) mRNA and this binding was dependent on Zn(2+). Results from sizing columns suggested that the active species might be in the form of an oligomer of MBP-TTP. Recombinant TTP was phosphorylated by three members of the mitogen-activated protein (MAP) kinase family, p42, p38, and JNK, with half-maximal phosphorylation occurring at approximately 0.5, 0.25, and 0.25 microM protein, respectively. Phosphorylation by these kinases did not appear to affect the ability of TTP to bind to TNFalpha mRNA under the assay conditions. This study describes a procedure for purifying nonfusion protein TTP to homogeneity, demonstrates that TTP's RNA-binding activity is zinc dependent, and that TTP can be phosphorylated by JNK as well as by the other members of the greater MAP kinase family.

Indexed as

DNA-Binding ProteinsMAP Kinase Signaling SystemAnimalsCarrier ProteinsElectrophoresis, Polyacrylamide GelEscherichia coliGlutathione TransferaseHumansImmediate-Early ProteinsImmunoblottingMaltose-Binding ProteinsMicePhosphorylationPlasmidsProtein BindingRecombinant Fusion ProteinsCarrier ProteinsDNA-Binding ProteinsGlutathione TransferaseImmediate-Early ProteinsMaltose-Binding ProteinsRecombinant Fusion ProteinsRecombinant ProteinsRNARNA, MessengerTristetraprolinTumor Necrosis Factor-alphaZFP36 protein, humanZfp36 protein, mouse

Identifiers

PMID12646273
PMCPMC1351391
OpenAlexW1964131816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.